MedTrace Logo

Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.

NCT02503254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2023-01-30

Study results available
· View outcomes & findings →

Summary

The overall goal of the study is to demonstrate the reduction of biomarkers of exposure (BoExp) to selected harmful and potentially harmful constituents (HPHCs) in adult smokers switching for 5 days from conventional cigarette (CC) to Carbon Heated Tobacco Product 1.0 (CHTP 1.0) as compared to smokers continuing to use CC.

Conditions

  • Smoking

Interventions

OTHER

CHTP 1.0

CHTP 1.0 ad libitum for 5 days in confinement

OTHER

Conventional Cigarette (CC)

Subject's own preferred brand of CC ad libitum for 5 days in confinement

Sponsors & Collaborators

  • Philip Morris Products S.A.

    lead INDUSTRY

Principal Investigators

  • Christelle Haziza, PhD · Philip Morris Products S.A.

  • Katarzyna Jarus-Dziedzic, MD, PhD · BioVirtus Research Site

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-09-30
Completion
2016-03-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02503254 on ClinicalTrials.gov